311 related articles for article (PubMed ID: 26064904)
1. Implication of Caspase-3 as a Common Therapeutic Target for Multineurodegenerative Disorders and Its Inhibition Using Nonpeptidyl Natural Compounds.
Khan S; Ahmad K; Alshammari EM; Adnan M; Baig MH; Lohani M; Somvanshi P; Haque S
Biomed Res Int; 2015; 2015():379817. PubMed ID: 26064904
[TBL] [Abstract][Full Text] [Related]
2. Caspase inhibition: a potential therapeutic strategy in neurological diseases.
Rideout HJ; Stefanis L
Histol Histopathol; 2001 Jul; 16(3):895-908. PubMed ID: 11510981
[TBL] [Abstract][Full Text] [Related]
3. Biological metals and metal-targeting compounds in major neurodegenerative diseases.
Barnham KJ; Bush AI
Chem Soc Rev; 2014 Oct; 43(19):6727-49. PubMed ID: 25099276
[TBL] [Abstract][Full Text] [Related]
4. Identification of potent caspase-3 inhibitors for treatment of multi- neurodegenerative diseases using pharmacophore modeling and docking approaches.
Ahmad K; Balaramnavar VM; Baig MH; Srivastava AK; Khan S; Kamal MA
CNS Neurol Disord Drug Targets; 2014; 13(8):1346-53. PubMed ID: 25345515
[TBL] [Abstract][Full Text] [Related]
5. The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.
Tan L; Yu JT; Tan L
J Neurol Sci; 2012 Dec; 323(1-2):1-8. PubMed ID: 22939820
[TBL] [Abstract][Full Text] [Related]
6. Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders.
Choonara YE; Pillay V; Du Toit LC; Modi G; Naidoo D; Ndesendo VMK; Sibambo SR
Int J Mol Sci; 2009 Jun; 10(6):2510-2557. PubMed ID: 19582217
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis.
Dunkel P; Chai CL; Sperlágh B; Huleatt PB; Mátyus P
Expert Opin Investig Drugs; 2012 Sep; 21(9):1267-308. PubMed ID: 22741814
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol: A Focus on Several Neurodegenerative Diseases.
Tellone E; Galtieri A; Russo A; Giardina B; Ficarra S
Oxid Med Cell Longev; 2015; 2015():392169. PubMed ID: 26180587
[TBL] [Abstract][Full Text] [Related]
9. The Potential of Flavonoids for the Treatment of Neurodegenerative Diseases.
Maher P
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234550
[TBL] [Abstract][Full Text] [Related]
10. Curcuminoids in neurodegenerative diseases.
Kim DS; Kim JY; Han Y
Recent Pat CNS Drug Discov; 2012 Dec; 7(3):184-204. PubMed ID: 22742420
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria and neurodegeneration.
Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
[TBL] [Abstract][Full Text] [Related]
12. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
Ciechanover A; Kwon YT
Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of cannabinoids in neurodegenerative disorders: a selective review.
Velayudhan L; Van Diepen E; Marudkar M; Hands O; Suribhatla S; Prettyman R; Murray J; Baillon S; Bhattacharyya S
Curr Pharm Des; 2014; 20(13):2218-30. PubMed ID: 23829360
[TBL] [Abstract][Full Text] [Related]
14. Harnessing the power of yeast to unravel the molecular basis of neurodegeneration.
Tenreiro S; Munder MC; Alberti S; Outeiro TF
J Neurochem; 2013 Nov; 127(4):438-52. PubMed ID: 23600759
[TBL] [Abstract][Full Text] [Related]
15. Advances in Applying Computer-Aided Drug Design for Neurodegenerative Diseases.
Salman MM; Al-Obaidi Z; Kitchen P; Loreto A; Bill RM; Wade-Martins R
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925236
[TBL] [Abstract][Full Text] [Related]
16. Effects of rosmarinic acid on nervous system disorders: an updated review.
Ghasemzadeh Rahbardar M; Hosseinzadeh H
Naunyn Schmiedebergs Arch Pharmacol; 2020 Oct; 393(10):1779-1795. PubMed ID: 32725282
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers of neurodegenerative disorders: how good are they?
Rachakonda V; Pan TH; LE WD
Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Autophagy in Neurodegenerative Diseases by Natural Products.
Liu S; Li X
Adv Exp Med Biol; 2020; 1207():725-730. PubMed ID: 32671789
[TBL] [Abstract][Full Text] [Related]
19. Prospects for antiapoptotic drug therapy of neurodegenerative diseases.
Waldmeier PC
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):303-21. PubMed ID: 12657369
[TBL] [Abstract][Full Text] [Related]
20. Kaempferol, a potential neuroprotective agent in neurodegenerative diseases: From chemistry to medicine.
Jin S; Zhang L; Wang L
Biomed Pharmacother; 2023 Sep; 165():115215. PubMed ID: 37494786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
